TY - JOUR
T1 - Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet?
AU - Kossoff, Eric H.
AU - Bosarge, Jennifer L.
AU - Miranda, Maria J.
AU - Wiemer-Kruel, Adelheid
AU - Kang, Hoon Chul
AU - Kim, Heung Dong
PY - 2010/12
Y1 - 2010/12
N2 - It has been reported that children can maintain seizure control when the ketogenic diet (KD) is transitioned to the less-restrictive modified Atkins diet (MAD). What is unknown, however, is the likelihood of additional seizure control from a switch from the MAD to the KD. Retrospective information was obtained from 27 patients who made this dietary change from four different institutions. Ten (37%) patients had ≥10% additional seizure reduction with the KD over the MAD, of which five became seizure-free. The five children who did not improve on the MAD failed to improve when transitioned to the KD. A higher incidence of improvement with the KD occurred for those with myoclonic-astatic epilepsy (70% vs. 12% for all other etiologies, p = 0.004), including all who became seizure-free. These results suggest that the KD probably represents a "higher dose" of dietary therapy than the MAD, which may particularly benefit those with myoclonic-astatic epilepsy.
AB - It has been reported that children can maintain seizure control when the ketogenic diet (KD) is transitioned to the less-restrictive modified Atkins diet (MAD). What is unknown, however, is the likelihood of additional seizure control from a switch from the MAD to the KD. Retrospective information was obtained from 27 patients who made this dietary change from four different institutions. Ten (37%) patients had ≥10% additional seizure reduction with the KD over the MAD, of which five became seizure-free. The five children who did not improve on the MAD failed to improve when transitioned to the KD. A higher incidence of improvement with the KD occurred for those with myoclonic-astatic epilepsy (70% vs. 12% for all other etiologies, p = 0.004), including all who became seizure-free. These results suggest that the KD probably represents a "higher dose" of dietary therapy than the MAD, which may particularly benefit those with myoclonic-astatic epilepsy.
UR - http://www.scopus.com/inward/record.url?scp=78650031127&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650031127&partnerID=8YFLogxK
U2 - 10.1111/j.1528-1167.2010.02774.x
DO - 10.1111/j.1528-1167.2010.02774.x
M3 - Article
C2 - 21204815
AN - SCOPUS:78650031127
SN - 0013-9580
VL - 51
SP - 2496
EP - 2499
JO - Epilepsia
JF - Epilepsia
IS - 12
ER -